Video bioinformatics analysis of human pluripotent stem cell morphology, quality, and cellular dynamics.

cell death growth human embryonic stem cells live-cell imaging motility pluripotent stem cells undifferentiated cells video

Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
09 2021
Historique:
revised: 04 04 2021
received: 17 11 2015
accepted: 20 04 2021
pubmed: 6 6 2021
medline: 7 4 2022
entrez: 5 6 2021
Statut: ppublish

Résumé

StemCellQC is a video bioinformatics software tool for the quantitative analysis of human pluripotent stem cell (hPSC) colonies. Our objective was to use StemCellQC to evaluate and compare various experimental culture conditions, cell lines, and treatments and to demonstrate its applicability to PSC problems. Seven key features were identified that provided useful information on PSC morphology, dynamic behavior, and viability. Colony attachment was better on laminin-521 than on Matrigel and Geltrex. Growth rates were similar on each matrix when data were normalized. The brightness/area ratio feature showed greater cell death in colonies grown on Matrigel and Geltrex than on laminin-521 further contributing to an overall greater yield of cells on laminin-521. Four different PSC culture media performed similarly; however, one medium produced batch-to-batch variation in colony morphology and dynamic features. Two embryonic and one induced pluripotent stem cell line showed significant differences in morphology, growth rates, motility, and death rates. Cells from the same vial that became phenotypically different in culture showed measurable differences in morphology, brightness, and motility. Likewise, differentiating and undifferentiated colonies varied in growth rate, intensity, and motility. Three pluripotent cell lines treated with a low concentration of cinnamaldehyde, a chemical used in consumer products, showed adverse effects and differed in their sensitivity to treatment. Our data demonstrate various applications of StemCellQC which could be used in basic and translational research, toxicological and drug testing, and clinical facilities engaged in stem cell therapy.

Identifiants

pubmed: 34089307
doi: 10.1002/sctm.15-0352
pmc: PMC8380446
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1343-1359

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA037365
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES029741
Pays : United States

Informations de copyright

© 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Références

Methods Mol Biol. 2011;690:31-56
pubmed: 21042983
Stem Cells Transl Med. 2018 Dec;7(12):867-875
pubmed: 30218497
Nat Methods. 2006 Aug;3(8):637-46
pubmed: 16862139
Stem Cell Reports. 2014 Jun 12;3(1):142-55
pubmed: 25068128
J Mol Med (Berl). 2012 Jul;90(7):735-45
pubmed: 22643868
Tob Control. 2016 Nov;25(Suppl 2):ii94-ii102
pubmed: 27633763
Stem Cells. 2008 Sep;26(9):2257-65
pubmed: 18599809
Cell Reprogram. 2020 Apr;22(2):43-54
pubmed: 32150690
Cell Stem Cell. 2009 Jul 2;5(1):111-23
pubmed: 19570518
Sci Rep. 2015 Sep 18;5:14209
pubmed: 26381699
Sci Rep. 2019 Feb 11;9(1):1777
pubmed: 30741960
Reprod Toxicol. 2012 Dec;34(4):529-37
pubmed: 22989551
J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):238-45
pubmed: 22820057
Nat Biotechnol. 2010 Oct;28(10):1115-21
pubmed: 20890283
Nat Commun. 2014;5:3195
pubmed: 24463987
Stem Cells. 2013 May;31(5):895-905
pubmed: 23335078
J Vis Exp. 2010 May 20;(39):
pubmed: 20495527
Toxicol Sci. 2010 Nov;118(1):202-12
pubmed: 20702591
Zygote. 2020 Jun;28(3):175-182
pubmed: 31965957
Nat Methods. 2011 May;8(5):424-9
pubmed: 21478862
Nat Biotechnol. 2009 Nov;27(11):1033-7
pubmed: 19826408
Sci Rep. 2018 Nov 5;8(1):16354
pubmed: 30397207
Stem Cells Transl Med. 2021 Sep;10(9):1343-1359
pubmed: 34089307
Stem Cells Transl Med. 2015 Jul;4(7):720-30
pubmed: 25972146
PLoS One. 2016 Feb 05;11(2):e0148642
pubmed: 26848582
Nat Protoc. 2014 Oct;9(10):2354-68
pubmed: 25211513
Nat Biotechnol. 2008 Mar;26(3):313-5
pubmed: 18278034

Auteurs

Sabrina C Lin (SC)

Department of Molecular, Cell and Systems Biology, University of California, Riverside, California, USA.

Antonio Loza (A)

Department of Molecular, Cell and Systems Biology, University of California, Riverside, California, USA.

Lauren Antrim (L)

Department of Molecular, Cell and Systems Biology, University of California, Riverside, California, USA.

Prue Talbot (P)

Department of Molecular, Cell and Systems Biology, University of California, Riverside, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH